Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mesenchymal stem cell therapy - K-STEMCELL

Next Previous
Drug Profile

Mesenchymal stem cell therapy - K-STEMCELL

Alternative Names: Adipose stem cell therapy - K-STEMCELL; Adult-derived stem cell therapy - K-STEMCELL; Astrostem; Astrostem®; Autologous adipose stem cells - K-STEMCELL; Autologous Adipose Tissue derived MSCs Transplantation - K-STEMCELL; Cancerstem®; Fat-derived stem cell therapy - K-STEMCELL; JointStem; Lipostem-DM; Lipostem-Femoran; RNL-JointStem; RNL-Vascostem; Vascostem

Latest Information Update: 13 Nov 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator RNL BIO
  • Developer Asan Medical Center; K-STEMCELL; Nature cell
  • Class Mesenchymal stem cell therapies; Stem cell therapies
  • Mechanism of Action Cartilage replacements; Cell replacements; Osteogenesis stimulants; Tissue replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Osteoarthritis
  • Phase II Alzheimer's disease
  • Phase I/II COVID-19 pneumonia; Femur head necrosis; Spinal cord injuries; Thromboangiitis obliterans
  • No development reported Cancer; Cerebral infarction; Cerebral palsy; Diabetes mellitus; Facial hemiatrophy; Fracture; Ischaemic heart disorders; Liver disorders; Peripheral vascular disorders

Most Recent Events

  • 24 Oct 2022 Phase-I/II clinical trials in COVID-19 pneumonia (Prevention) in USA (IV) (NCT04527224)
  • 26 May 2021 Phase-II/III clinical trials in Osteoarthritis (Treatment-experienced) in USA (Intra-articular) (NCT04368806)
  • 01 Apr 2021 R-Bio plans a clinical trial for Knee osteoarthritis (Intra-articular) in December 2021 (NCT04825730)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top